Purchases and Sales Made in Q3 2024 in Mereo Biopharma Group PLC (MREO)
This table provides information about the institutional ownership of Mereo Biopharma Group PLC (MREO) during Q3 2024. The information is specifically focused on institutions that hold shares of Mereo Biopharma Group plc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-457K- 25.92% |
$1.58M - $2.22M
|
1.31M
$3.73M
|
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-499K- 19.91% |
$1.72M - $2.43M
|
2.01M
$5.74M
|
|
|
Nov 14, 2024
Q3 2024
|
Integral Health Asset Management, LLC
|
SELL
|
- |
-775K- 43.66% |
$2.67M - $3.77M
|
1M
$2.86M
|
|
|
Nov 14, 2024
Q3 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-2.08M- 17.61% |
$7.16M - $10.1M
|
9.72M
$27.8M
|